Ferric Carboxymaltose to Improve Skeletal Muscle Metabolism in Heart Failure Patients With Functional Iron Deficiency
Clinical trial NCT03218384 · TERMINATED
Trial details
- NCT number
- NCT03218384
- Sponsor
- NYU Langone Health
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-07
- Primary completion
- 2022-04-04
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.